
Memphasys Limited (MEM.AX) Pivotal Clinical Trial Confirms Best-in-Class Performance
Defining Milestone for Memphasys, Felix(TM) Pivotal Clinical Trial Confirms Best-in-Class Performance - Paving the Way for Global Commercial Expansion Sydney, Mar 24, 2025 AEST (ABN Newswire) - Memphasys Limited (ASX:MEM) (IG7:FRA) is pleased to announce …